January 24, 2008
Suicide Studies in Drug Trials Required by FDA
Gardiner Harris writes in today's New York Times that The FDA is now requiring drug companies to study closely the impact of the drugs on patients during clinical trials, and that "[t]he new rules represent one of the most profound changes of the past 16 years to regulations governing drug development." The agency's shift has not been announced publicly because the F.D.A.’s oversight of experimental medicines is done in secret.
January 24, 2008 | Permalink
TrackBack URL for this entry:
Listed below are links to weblogs that reference Suicide Studies in Drug Trials Required by FDA:
Tracked on Sep 21, 2009 8:58:18 AM
Tracked on Sep 22, 2009 11:53:24 AM